Search details
1.
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
Mol Cancer
; 23(1): 10, 2024 01 10.
Article
in English
| MEDLINE | ID: mdl-38200602
2.
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Int J Cancer
; 154(12): 2142-2150, 2024 Jun 15.
Article
in English
| MEDLINE | ID: mdl-38447003
3.
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment.
J Pathol
; 257(5): 607-619, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35373359
4.
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Int J Cancer
; 150(8): 1341-1349, 2022 04 15.
Article
in English
| MEDLINE | ID: mdl-34807464
5.
Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma.
Liver Int
; 42(12): 2855-2870, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35983950
6.
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP.
Br J Cancer
; 124(4): 721-727, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33235314
7.
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
Oncologist
; 26(3): e414-e424, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33274542
8.
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
Strahlenther Onkol
; 197(1): 19-26, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32638040
9.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Article
in English
| MEDLINE | ID: mdl-30982686
10.
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.
Ann Surg Oncol
; 27(7): 2389-2401, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32172334
11.
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]. / Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom Interdisziplinäre Empfehlungen.
Z Gastroenterol
; 58(6): 577-582, 2020 Jun.
Article
in German
| MEDLINE | ID: mdl-32544967
12.
Concomitant metastatic head-and-neck cancer and pancreatic cancer assessed by αvß6-integrin PET/CT using 68Ga-Trivehexin: incidental detection of a brain metastasis.
Eur J Nucl Med Mol Imaging
; 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38771514
13.
"Liquid Biopsy Stellenwert in der gastrointestinalen Onkologie".
Zentralbl Chir
; 146(2): 148-151, 2021 04.
Article
in German
| MEDLINE | ID: mdl-33851378
14.
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 16(8): 979-89, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26189067
15.
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.
Br J Cancer
; 113(7): 1027-34, 2015 Sep 29.
Article
in English
| MEDLINE | ID: mdl-26355232
16.
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Lancet Oncol
; 15(8): 862-73, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24928083
17.
Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer.
BMC Cancer
; 14: 521, 2014 Jul 19.
Article
in English
| MEDLINE | ID: mdl-25038824
18.
Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.
J Clin Oncol
; 42(13): 1531-1541, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38412408
19.
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
Oncol Res Treat
; 47(6): 251-261, 2024.
Article
in English
| MEDLINE | ID: mdl-38565089
20.
Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced population.
BMC Cancer
; 13: 66, 2013 Feb 07.
Article
in English
| MEDLINE | ID: mdl-23391192